Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)
NCT ID: NCT04305977
Last Updated: 2023-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-10-22
2021-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HIV Prevention Intervention for Young Transgender Women
NCT01575938
Transgender Men's Perspectives on HIV Risk and HIV Prevention Interventions
NCT05666102
Striving Towards EmPowerment and Medication Adherence (STEP-AD)
NCT02764853
Addressing Violence and HIV Care Among Transgender Women
NCT04813484
Transgender Cohort Study of Gender Affirmation and HIV-related Health
NCT03595956
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
WAVE-TW Arm
All participants will receive the WAVE-TW intervention.
WAVE-TW
The WAVE-TW open pilot trial of the intervention consists of 5 sessions conducted individually with each part participant. Each session lasts approximately 30-50 minutes. The first session will be the LifeSteps Adherence session that focuses on cognitive-behavioral and problem-solving techniques to promote adherence. The next four sessions will be dedicated to trauma writing.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WAVE-TW
The WAVE-TW open pilot trial of the intervention consists of 5 sessions conducted individually with each part participant. Each session lasts approximately 30-50 minutes. The first session will be the LifeSteps Adherence session that focuses on cognitive-behavioral and problem-solving techniques to promote adherence. The next four sessions will be dedicated to trauma writing.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 or older
* Detectable viral load within the past year
* Transgender female
* English speaking
* Capable of completing and fully understanding the informed consent process and the study procedures
* History of trauma/abuse
Exclusion Criteria
* Significant interfering mental health symptoms (e.g., untreated active psychosis, active suicidality with a plan).
* Engaged in an intervention to address trauma symptoms and adherence within the past year
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Empower U Community Health Center
UNKNOWN
Miami Center for AIDS Research at the University of Miami Miller School of Medicine
UNKNOWN
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sannisha K Dale
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sannisha Dale, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UHealth Don Soffer Clinical Research Building
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20190722
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.